Treatment of female pattern hair loss with a combination of spironolactone and minoxidil
Authors:
- 11 January 2007
- journal article
- case report
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 48 (1) , 43-45
Abstract
SUMMARY: A 53‐year‐old woman with clinical evidence of female pattern hair loss and histological evidence of androgenetic alopecia was initially treated with the oral antiandrogen spironolactone 200 mg daily. Serial scalp photography documented hair regrowth at 12 months; however, the hair regrowth plateaued, and at 24 months there had been no further improvement in hair density. Twice daily therapy with topical minoxidil 5% solution was then introduced and further regrowth documented, confirming the additive effect of combination therapy.Keywords
This publication has 5 references indexed in Scilit:
- Antiandrogen therapy for androgenetic alopeciaExpert Review of Dermatology, 2006
- Treatment of female pattern hair loss with oral antiandrogensBritish Journal of Dermatology, 2005
- A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair lossJournal of the American Academy of Dermatology, 2004
- Minoxidil: mechanisms of action on hair growthBritish Journal of Dermatology, 2004
- Studies on the destruction of adrenal and testicular cytochrome P-450 by spironolactone. Requirement for the 7alpha-thio group and evidence for the loss of the heme and apoproteins of cytochrome P-450.Journal of Biological Chemistry, 1979